These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7911993)

  • 21. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1.
    Galina ZH; Kastin AJ
    Life Sci; 1986 Dec; 39(23):2153-9. PubMed ID: 2878336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental, behavioral, and opiate receptor changes after prenatal or postnatal beta-endorphin, CRF, or Tyr-MIF-1.
    Zadina JE; Kastin AJ; Coy DH; Adinoff BA
    Psychoneuroendocrinology; 1985; 10(4):367-83. PubMed ID: 2868478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain peptide reverses effect of morphine on human lymphocytes.
    Strimas JH; Chi DS; Kastin AJ
    Peptides; 1987; 8(6):1165-7. PubMed ID: 2894648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
    Miller LG; Kastin AJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1987 Dec; 28(4):521-4. PubMed ID: 2893390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro studies of Tyr-MIF-1 with human lymphocytes.
    Chi DS; Strimas JH; Kastin AJ
    Brain Res Bull; 1989 Dec; 23(6):549-52. PubMed ID: 2575445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of Tyr-MIF-1 at opiate receptor sites.
    Zadina JE; Kastin AJ
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1303-5. PubMed ID: 2880352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
    Sander GE; Kastin AJ; Giles TD
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1301-3. PubMed ID: 6131437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Hirst M
    Peptides; 1986; 7(6):1007-10. PubMed ID: 2882493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats.
    Malin DR; Zadina JE; Lake JR; Rogillio RB; Leyva JE; Benson TM; Corriere LS; Handunge BP; Kastin AJ
    Brain Res; 1993 Apr; 610(1):169-71. PubMed ID: 8100171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats.
    Hayashi T; Fischman AJ; Kastin AJ; Coy DH
    Pharmacol Biochem Behav; 1984 Nov; 21(5):809-12. PubMed ID: 6151198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM; Kastin AJ
    Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of neonatal treatment with Tyr-MIF-1 and naloxone on the long-term body weight gain induced by repeated postnatal stressful stimuli.
    d'Amore A; Loizzo A
    Peptides; 1999 Dec; 20(12):1425-30. PubMed ID: 10698117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family.
    Zamfirova R; Bocheva A; Dobrinova Y; Todorov S
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):93-8. PubMed ID: 17391278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.
    Kastin AJ; Abel DA; Ehrensing RH; Coy DH; Graf MV
    Pharmacol Biochem Behav; 1984 Nov; 21(5):767-71. PubMed ID: 6151196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.